Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women

Blood

Volumn 126, Issue 17, 2015, Pages 1981-1989

  Moretti, Diego ^a   Goede, Jeroen S ^b   Zeder, Christophe ^a   Jiskra, Markus ^a   Chatzinakou, Vaiya ^a   Tjalsma, Harold ^d   Melse Boonstra, Alida ^c   Brittenham, Gary ^a,e   Swinkels, Dorine W ^d   Zimmermann, Michael B ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e College of Physicians and Surg ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEPCIDIN; IRON; TRANSFERRIN; BIOLOGICAL MARKER; IRON INTAKE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IRON ABSORPTION; IRON THERAPY; LIMIT OF DETECTION; MORNING DOSAGE; NORMAL HUMAN; PREDICTION; PREVALENCE; PRIORITY JOURNAL; TIME OF FLIGHT MASS SPECTROMETRY; ADMINISTRATION AND DOSAGE; ADOLESCENT; BIOAVAILABILITY; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG ADMINISTRATION; FOLLOW UP; INTESTINE ABSORPTION; IRON INTAKE; MALE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BIOLOGICAL AVAILABILITY; BIOMARKERS; CASE-CONTROL STUDIES; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEPCIDINS; HUMANS; INTESTINAL ABSORPTION; IRON; IRON, DIETARY; MALE; MIDDLE AGED; PROGNOSIS; YOUNG ADULT;

EID: 84944736888     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-05-642223     Document Type: Article

References (40)

1. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123(5):615-624.
2. Cogswell ME, Looker AC, Pfeiffer CM, et al. Assessment of iron deficiency in US preschool children and nonpregnant females of childbearing age: National Health and Nutrition Examination Survey 2003-2006. Am J Clin Nutr. 2009;89(5):1334-1342.
3. Cook JD. Diagnosis and management of irondeficiency anaemia. Best Pract Res Clin Haematol. 2005;18(2):319-332.
4. Peña-Rosas JP, De-Regil LM, Dowswell T, Viteri FE. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2012;7:CD009997.
5. Smith GA, Fisher SA, Doree C, Di Angelantonio E, Roberts DJ. Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors. Cochrane Database Syst Rev. 2014;7:CD009532.
6. Cook JD, Reddy MB. Efficacy of weekly compared with daily iron supplementation. Am J Clin Nutr. 1995;62(1):117-120.
7. Zimmermann MB, Chassard C, Rohner F, et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am J Clin Nutr. 2010;92(6):1406-1415.
8. Jaeggi T, Kortman GA, Moretti D, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64(5):731-742.
9. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (0).
10. Shah YM, Matsubara T, Ito S, Yim SH, Gonzalez FJ. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab. 2009;9(2):152-164.
11. Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr. 2008;28:197-213.
12. Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S, Peyssonnaux C. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest. 2009;119(5):1159-1166.
13. Mastrogiannaki M, Matak P, Peyssonnaux C. The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions. Blood. 2013;122(6):885-892.
14. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271-1276.
15. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood. 2007;110(6):2182-2189.
16. Zimmermann MB, Troesch B, Biebinger R, Egli I, Zeder C, Hurrell RF. Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stableisotope appearance curves, increases plasma hepcidin. Am J Clin Nutr. 2009;90(5):1280-1287.
17. Roe MA, Collings R, Dainty JR, Swinkels DW, Fairweather-Tait SJ. Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr. 2009;89(4):1088-1091.
18. Kroot JJ, Hendriks JC, Laarakkers CM, et al. (Pre) analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem. 2009;389(2):124-129.
19. Schaap CC, Hendriks JC, Kortman GA, et al. Diurnal rhythm rather than dietary iron mediates daily hepcidin variations. Clin Chem. 2013;59(3):527-535.
20. Stoltzfus R, Dreyfuss ML. Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia. In: INACG ed. Washington, D. C: ILSI; 1998.
21. CDC. Recommendations to Prevent and Control Iron Deficiency in the United States. Morb Mortal Wkly Rep. 1998;47(RR1-3):1-36.
22. hematology Bcfsi. UK guidelines for management of iron deficiency in pregnancy. London: British Society for Hematology; 2011.
23. Guideline WHO. Intermittent iron and folic acid supplementation in menstruating women. Geneva: WHO; 2011.
24. WHO. Daily iron and folic acid supplementation in pregnant women. World Health Organization; 2012.
25. WHO. Intermittent iron and folic acid supplementation in non-anemic pregnant women. Geneva: World Health Organization; 2012.
26. Moretti D, Zimmermann MB, Wegmüller R, Walczyk T, Zeder C, Hurrell RF. Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans. Am J Clin Nutr. 2006;83(3):632-638.
27. Erhardt JG, Estes JE, Pfeiffer CM, Biesalski HK, Craft NE. Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked immunosorbent assay technique. J Nutr. 2004;134(11):3127-3132.
28. Iron Panel of the International Committee for Standardization in Haematology. Revised recommendations for the measurements of the serum iron in human blood. Br J Haematol. 1990;75(4):615-616.
29. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood. 2003;101(9):3359-3364.
30. Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, et al. Immunochemical and mass-spectrometrybased serum hepcidin assays for iron metabolism disorders. Clin Chem. 2010;56(10):1570-1579.
31. Hotz K, Krayenbuehl PA, Walczyk T. Mobilization of storage iron is reflected in the iron isotopic composition of blood in humans. J Biol Inorg Chem. 2012;17(2):301-309.
32. Cook JD, Dassenko SA, Lynch SR. Assessment of the role of nonheme-iron availability in iron balance. Am J Clin Nutr. 1991;54(4):717-722.
33. WHO Guidelines Approved by the Guidelines Review Committee. Guideline: Intermittent Iron Supplementation in Preschool and School-Age Children. Geneva: World Health Organization. Copyright (c) World Health Organization 2011.; 2011.
34. WHO Guidelines Approved by the Guidelines Review Committee. Guideline: Intermittent Iron and Folic Acid Supplementation in Menstruating Women. Geneva: World Health Organization Copyright (c) World Health Organization 2011.; 2011.
35. Wilkinson N, Pantopoulos K. The IRP/IRE system in vivo: insights from mouse models. Front Pharmacol. 2014;5:176.
36. Vanoaica L, Darshan D, Richman L, Schümann K, Kühn LC. Intestinal ferritin H is required for an accurate control of iron absorption. Cell Metab. 2010;12(3):273-282.
37. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090-2093.
38. Prentice AM, Doherty CP, Abrams SA, et al. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood. 2012;119(8):1922-1928.
39. Wheby MS. Effect of iron therapy on serum ferritin levels in iron-deficiency anemia. Blood. 1980;56(1):138-140.
40. Ramos E, Kautz L, Rodriguez R, et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology. 2011;53(4):1333-1341.